Mrs. Monica E Messmer-tunnell, PT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2608 W Kenosha St # 496, Broken Arrow, OK 74012 Phone: 918-284-4220 Fax: 918-249-2817 |
Dr. Shane Lee Casey, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 20208 E 37th St S, Broken Arrow, OK 74014 Phone: 405-808-8128 |
Suruchi Taneja, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1200 W Albany St, Broken Arrow, OK 74012 Phone: 918-744-2338 |
Jodi L Yelverton, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1200 W Albany St, Broken Arrow, OK 74012 Phone: 817-284-9850 Fax: 817-284-9859 |
News Archive
"Pakistan Tuesday claimed progress in vaccinating thousands of children against polio in a tribal area bordering Afghanistan which had been inaccessible due to unrest for about three years," Agence France-Presse reports.
Understanding how cancer cells communicate with each other and how to enhance their receptiveness to drug treatments is the focus of promising work by a Kansas State University researcher.Annelise Nguyen, assistant professor of toxicology in the department of diagnostic medicine and pathobiology at K-State's College of Veterinary Medicine, recently received a $370,000 grant from the National Institutes of Health to continue her cancer research.
A new treatment may diminish a dangerous side effect associated with transfusions of red blood cells (RBCs) known as pulmonary hypertension, an elevated blood pressure in the lungs and heart that can lead to heart failure, suggests a new study published in the November issue of Anesthesiology, the peer-reviewed medical journal of the American Society of Anesthesiologists.
U.S. Department of Health and Human Services awarded two contracts today to help make vaccine available more quickly for seasonal flu outbreaks and pandemics. The contracts for advanced development of new types of vaccine and new ways to make flu vaccine known as next-generation recombinant influenza vaccine total $215 million.
Emisphere Technologies, Inc. today announced that it has entered into an expanded relationship with Novartis Pharma AG pursuant to which Novartis has cancelled the Company's Convertible Promissory Note. The Note was originally issued to Novartis on December 1, 2004 in connection with the Research Collaboration and Option License Agreement between the parties of that date and was originally due December 1, 2009. Previously, Novartis had agreed to extend the maturity date to June 4, 2010.
› Verified 9 days ago